Become an EMPEA Member Today

Impact Case Study: Genomma Lab

Posted on: 11 Jun 2012

DOWNLOAD FULL STUDY

Nexxus Capital invested US$17.75 million for a 30% stake and exited with an investment IRR of 72.9% and a cost multiple of 18.5x

  • Company Headquarters: Mexico
  • Business focus: Pharmaceuticals and consumer products
  • Revenue: US$596 million in 2011

Impact Highlights

  • Nexxus Capital helped Genomma Lab grow from a mid-sized company managed by a group of friends into a large, strategically focused and professionally managed public company

  • Nexxus Capital supported Genomma Lab in becoming the first Mexican pharmaceutical company to list on Mexico’s stock exchange in 2008; since its IPO, Genomma Lab’s shares have appreciated over 350%

  • Genomma Lab completed more than 20 acquisitions during its partnership with Nexxus Capital, expanding into 12 countries and achieving market share leadership in many of its target product categories

  • With Nexxus Capital as a partner, Genomma Lab has received recognitions for its social responsibility and inclusiveness; the company has also been an active donor of relief funds and supplies when natural disasters have occurred in Mexico and Latin America

< Previous Entry

Next Entry >